News

Fennec Pharmaceuticals Set to Shine at Upcoming Healthcare Event

Fennec Pharmaceuticals Set to Shine at Upcoming Healthcare Event

Fennec Pharmaceuticals to Join Piper Sandler Conference

Fennec Pharmaceuticals Inc. (NASDAQ: FENC, TSX: FRX), a leading specialty pharmaceutical company, has announced its participation in a prominent healthcare event this upcoming December. The company plans to hold a fireside chat during the Piper Sandler 37th Annual Healthcare Conference, which will be available for webcast. This conference offers an exceptional platform for Fennec to discuss its innovative approaches in addressing ototoxicity in cancer patients.

Webcast and Conference Details

The announcement includes key details about the upcoming webcast. On December 3, attendees can tune in at 1:00 p.m. ET to hear from Fennec’s management team. This live event will allow cancer care stakeholders and interested listeners to learn more about the company's mission and products. A link to the webcast will be shared ahead of the event, ensuring easy access for those who want to participate.

What to Expect from the Chat

During the fireside chat, attendees can expect insightful discussions surrounding Fennec's efforts to mitigate the risks of ototoxicity associated with cisplatin therapy in pediatric patients. The conversation aims to shed light on how the company's flagship product, PEDMARK, plays a critical role in this area.

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals is dedicated to combating the significant challenges posed by ototoxicity in patients undergoing cisplatin-based chemotherapy. The company's leading product, PEDMARK, is geared toward minimizing this risk. PEDMARK gained FDA approval in late 2022, followed closely by approvals in Europe and the United Kingdom, demonstrating Fennec's strong commitment to improving patient outcomes.

Recent Developments and Partnerships

Recently, in early 2024, Fennec announced an exclusive licensing agreement with Norgine Pharmaceuticals Ltd., allowing them to commercialize PEDMARQSI in various international markets including Europe, the U.K., Australia, and New Zealand. This partnership is indicative of Fennec's exponential reach and rapid growth in the specialty pharmaceuticals sector.

Market Position and Patient Impact

The company holds significant patents that ensure the protection of PEDMARK until 2039, allowing them to maintain a competitive edge. The products have received Orphan Drug Exclusivity in the U.S. and impressive market protections in Europe, including Pediatric Use Marketing Authorization. These accolades underscore Fennec's dedication to improving treatment standards for pediatric oncology patients.

Stay Informed with Fennec Pharmaceuticals

For more information on Fennec Pharmaceuticals and their product offerings, stakeholders are encouraged to visit their official website. The company's continuous updates and insights into their research and initiatives make it an important resource for interested parties.

Contact Information

If you would like further details, Fennec has provided contact information for investor relations and media inquiries:

Investors:
Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
+1 919-246-5299

Corporate and Media:
Lindsay Rocco
Elixir Health Public Relations
+1 862-596-1304
lrocco@elixirhealthpr.com

Frequently Asked Questions

What is the significance of the Piper Sandler Conference for Fennec?

This conference allows Fennec to showcase their innovative products and connect with healthcare stakeholders.

When will the fireside chat take place?

The fireside chat is scheduled for December 3 at 1:00 p.m. ET, with details available prior to the event.

What is PEDMARK and its importance?

PEDMARK is Fennec's product designed to reduce the risk of ototoxicity in pediatric cancer patients receiving cisplatin.

Who is partnering with Fennec for international marketing?

Norgine Pharmaceuticals Ltd. has signed an exclusive licensing agreement to commercialize PEDMARQSI in multiple countries.

How can investors keep track of Fennec's progress?

Investors can stay updated by visiting the company's website for the latest news and updates regarding their initiatives and products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sportradar and DATA.BET: Expanding Esports Odds Offering

Updated Category News Views 168

A Shift in the Esports Betting Landscape Well, it looks like we’ve hit another significant milestone in the esports betting universe. Sportradar, the sports tech giant known for pushing boundaries, has forged an intriguing alliance with DATA.BET, a sportsbook hotshot hailing from Cyprus. We're talking about a deal that’s set to shake up the esports betting scene with...

Continue Reading
AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 99

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
Choosing Dance Styles: Tips from Expert Instructors

Updated Category News Views 77

Navigating the Dance Style Maze Picking a dance style is no joke, especially when every option seems to spin its own tale. It ain't just about twirling to your favorite rhythm. There's a whole spectrum of styles, from graceful ballet to punchy hip-hop, each with its ticklish quirks and temptations. Sandy Young and Jenna Engen, dance experts from Young Dance Academy Inc....

Continue Reading
Dyania, NVIDIA Team Up: AI Transforming Patient Care

Updated Category News Views 12

Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 178

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Aluminum Fluoride Market to Hit $3.3B by 2031

Updated Category News Views 124

Eye on the Aluminum Fluoride Surge Cracking open the numbers, the aluminum fluoride market is projected to swell from $2.48 billion in 2026 to a hefty $3.30 billion by 2031, trucking along at a CAGR of 5.9%. That's no small potatoes in the world of industrial materials. Scratch the surface, and you’ll see what's fueling this climb—think of it as a bellwether for...

Continue Reading
Classys Rides Revenue Surge, Eyes China Growth

Updated Category News Views 108

Strong Numbers, But There's More to Unpack Nine months into 2026, Classys Inc. ain't exactly putting up shabby numbers. They've rolled in with KRW 275.7 billion like it was a stroll in the park, marking a sturdy 13% jump from last year. Yet, with all this, their operating profit has taken a 9.4% spill. It's a mixed bag, folks, and Classys is gearing up for a massive...

Continue Reading
Timken Maintains Robust Dividend Streak in 2026

Updated Category News Views 134

Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...

Continue Reading
vVARDIS Readies for Big Day on NYSE—IPO Set to Shine

Updated Category News Views 157

vVARDIS Stepping into the Spotlight of the NYSE Alright, folks, here's one that could make some waves. vVARDIS is gearing up for its NYSE debut, trading under the ticker VVVV. They're no small fry talking about 9.72 million shares priced at 18 bucks a pop. This isn't just any run-of-the-mill company; they claim to have the first peptide-containing formulation for early...

Continue Reading
Duke Energy's Cooling Tips Amid Florida Cold Front

Updated Category News Views 163

Weather Whiplash in Florida Prompts Energy Tips Florida's residents are in for a gust of chilly air as a cold front sweeps across the state, sending temperatures plummeting from the balmy 80s to brisk 30s and 40s in northern pockets. Central Florida ain't missing out on the chill either, expecting to dip a good dozen degrees below its usual seasonal warmth. Heads up,...

Continue Reading

Top 5 Most Recently Viewed Articles

Central Banks' Rate Decisions: Market Reactions and Impacts

Updated Category News Views 264

Central Banks' Rate Decisions: What’s Coming Up? The upcoming week promises to be a significant one, as major central banks gear up to announce their latest monetary policy choices. All eyes are on the Federal Reserve, the Bank of England, and the Bank of Japan, each of which plays a crucial role in shaping global markets. Investors are eagerly awaiting these...

Continue Reading
Venterra Realty Unveils Stunning Delta Pearland Apartments

Updated Category News Views 208

Venterra Realty Announces Grand Opening of New Apartments Venterra Realty is excited to share news about the recent grand opening of The Delta Pearland, a stunning new apartment community located at 7300 Magnolia Pkwy. This luxury multifamily project has been crafted with care and is set to meet the growing demand for quality housing. Expanding Development Portfolio The...

Continue Reading
Tesla Stock Insights: Key Price Levels to Watch Now

Updated Category News Views 137

Tesla Stock Sees Significant Gains Tesla shares have recently jumped by over 4%, breaking free from the downward trend affecting many large-cap technology stocks. Despite the market's volatility, Tesla's resilience stands out. Quarterly Performance and Future Outlook In the past three months, Tesla's stock has risen approximately 25%. However, it appears to be in a...

Continue Reading
Sam Charney Recognized as Outstanding Developer of the Year

Updated Category News Views 180

Celebrating a Visionary Leader in Real Estate Over 300 real estate professionals gathered for the prestigious RED Residential Awards, an event dedicated to honoring innovators and leaders within the industry. This year marked a special celebration as the 13th Annual Awards took place in a vibrant atmosphere, recognizing outstanding contributions to residential real...

Continue Reading
Aeries Technology's Strategic Growth and Future Prospects

Updated Category News Views 154

Aeries Technology's Ambitious Growth Plans Aeries Technology, Inc. (NASDAQ: AERT), renowned for its expertise in AI-driven business transformation and Global Capability Center (GCC) services, has set its sights on a promising future, anticipating a remarkable lift in its annual revenue run-rate. With two newly secured enterprise agreements, the company is poised to exceed...

Continue Reading